Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
1.780
+0.140 (8.54%)
At close: Nov 21, 2024, 4:00 PM
1.790
+0.010 (0.56%)
After-hours: Nov 21, 2024, 4:57 PM EST
Werewolf Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for HOWL stock have an average target of 13.5, with a low estimate of 12 and a high estimate of 15. The average target predicts an increase of 658.43% from the current stock price of 1.78.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HOWL stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +742.70% | Nov 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +742.70% | Jul 2, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +574.16% | Jun 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +742.70% | Jun 26, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +574.16% | Jun 4, 2024 |
Financial Forecast
Revenue This Year
3.51M
from 19.94M
Decreased by -82.42%
Revenue Next Year
10.23M
from 3.51M
Increased by 191.98%
EPS This Year
-1.68
from -1.05
EPS Next Year
-1.98
from -1.68
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.5M | 52.5M | 52.5M | ||
| Avg | 3.5M | 10.2M | 10.2M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -52.5% | 1,397.9% | 413.0% | ||
| Avg | -82.4% | 192.0% | -0.3% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.48 | -1.08 | -1.25 | ||
| Avg | -1.68 | -1.98 | -2.05 | ||
| Low | -2.03 | -4.36 | -3.97 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.